Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARIFLO in Chronic Obstructive Pulmonary Disease (COPD)
NCT00103922Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2004
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cilomilast in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Started Nov 2004; status: completed.
02
Drugs
cilomilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00103922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103922.